Highlights and Quick Summary
- Change in payables and accrued liability for the quarter ending September 30, 2022 was $-19.2 Million (a -232.75% decrease compared to previous quarter)
- Year-over-year quarterly Change in payables and accrued liability decreased by -184.4%
- Annual Change in payables and accrued liability for 2021 was $39.4 Million (a 127.09% increase from previous year)
- Annual Change in payables and accrued liability for 2020 was $17.4 Million (a 47.82% increase from previous year)
- Annual Change in payables and accrued liability for 2019 was $11.7 Million (a 161.67% increase from previous year)
- Twelve month Change in payables and accrued liability ending September 30, 2022 was $-4.92 Million (a -117.44% decrease compared to previous quarter)
- Twelve month trailing Change in payables and accrued liability decreased by -112.48% year-over-year
Trailing Change in payables and accrued liability for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| $-4.92 Million | $28.2 Million | $23.9 Million | $39.4 Million |
Visit stockrow.com/BCRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Change in payables and accrued liability of BioCryst Pharmaceuticals, Inc.
Most recent Change in payables and accrued liabilityof BCRX including historical data for past 10 years.Interactive Chart of Change in payables and accrued liability of BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. Change in payables and accrued liability for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $-19.18 | $14.45 | $-22.91 | – |
| 2021 | $22.72 | $13.95 | $10.12 | $-7.37 | $39.41 |
| 2020 | $10.63 | $7.88 | $3.94 | $-5.1 | $17.36 |
| 2019 | $1.77 | $9.98 | $4.01 | $-1.43 | $11.74 |
| 2018 | – | – | $4.49 | $4.45 | $4.49 |
| 2017 | – | $3.84 | $-2.62 | $1.64 | $3.84 |
| 2016 | $1.54 | $-3.32 | $-8.2 | $-0.54 | $-10.52 |
| 2015 | $1.09 | $3.97 | $5.21 | $3.4 | $13.68 |
| 2014 | $1.05 | $3.85 | $2.01 | $-2.25 | $4.66 |
| 2013 | – | $2.15 | $0.04 | $-7.11 | – |
| 2012 | $5.85 | $-1.2 | $0.22 | $-2.79 | $2.07 |
Business Profile of BioCryst Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology